⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1746024 | 0.97 | — | — | |
| Lithium SCHEMBL8040608 | 0.97 | — | — | |
| Lithium SCHEMBL9464923 | 0.82 | ABAT (0.35) | — | |
| SCHEMBL12423753 | 0.79 | — | — | |
| SCHEMBL15684113 | 0.79 | — | — | |
| SCHEMBL5729035 | 0.79 | — | — | |
| SCHEMBL1665954 | 0.78 | GABRP (0.39) | — | |
| SCHEMBL1030281 | 0.77 | GABRR1 (0.39) | — | |
| SCHEMBL1030623 | 0.77 | GABRR1 (0.39) | — | |
| SCHEMBL8413192 | 0.77 | GABRR1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 552 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707276-A2 | MALT1 MODULATORS AND USES THEREOF | Rarefied Biosciences, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4499611-B1 | MALT1 MODULATORS AND USES THEREOF | RAREFIED BIOSCIENCES INC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20250326738-A1 | MALT1 Modulators and Uses Thereof | RAREFIED BIOSCIENCES, INC. (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4634159-A1 | SULFOXIMINES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2025-10-22 | — | — | EP | disclosed |
| US-20250221966-A1 | RXFP1 AGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2025-07-10 | — | — | US | disclosed |
| WO-2025036490-A1 | DNA POLYMERASE θ INHIBITOR AND USE THEREOF | 海思科医药集团股份有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2025026266-A1 | COMPOUND AS LPAR1 ANTAGONIST, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 武汉朗来科技发展有限公司 | 2025-02-06 | — | — | WO | disclosed |
| EP-4499611-A1 | MALT1 MODULATORS AND USES THEREOF | Rarefied Biosciences, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| US-20240391926-A1 | SPIROINDOLINONE COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS | D.E. SHAW RESEARCH, LLC | 2024-11-28 | — | — | US | disclosed |
| CN-119032083-A | MALT1 modulators and uses thereof | 稀有生物科学股份有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-6683212-B1 | N-(1-(2-NAPHTHALENYL)ETHYL)CYCLOBUTANECARBOXAMIDE DERIVATIVES; PLANT DISEASES; CROPS; AGRICULTURE | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-01-27 | — | — | US | disclosed |
| US-20030191189-A1 | Fungicidal amides | BASARAB GREGORY S (US) | 2003-10-09 | — | — | US | disclosed |
| US-6504058-B1 | (1(R)-cis)-3-chloro-1,3-dimethyl-N-(1-(2-napthalenyl)ethyl) -cyclobutanecarboxamide and/or isomers, used for controlling plant diseases caused by fungi | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS | 2003-01-07 | — | — | US | disclosed |
| WO-1999031048-A1 | FUNGICIDAL AMIDES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 1999-06-24 | — | — | WO | disclosed |
| US-5384072-A | Liquid crystals | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-01-24 | — | — | US | disclosed |
| EP-0576450-A1 | METHYLENE CYCLOBUTANE DERIVATES | MERCK PATENT GmbH (DE) | 1994-01-05 | — | — | EP | disclosed |
| US-5246931-A | Triazine-substituted cyclobutane derivatives; viricides; side effect reduction | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-09-21 | — | — | US | disclosed |
| US-5153352-A | Viricides and antitumor agent | BRISTOL-MYERS SQUIBB COMPANY (US) | 1992-10-06 | — | — | US | disclosed |
| WO-1992016483-A1 | METHYLENE CYCLOBUTANE DERIVATES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1992-10-01 | — | — | WO | disclosed |
| EP-0366059-A2 | Carbocyclic nucleoside analogs | BRISTOL-MYERS SQUIBB COMPANY (US) | 1990-05-02 | — | — | EP | disclosed |